Systemic vascular effects of thrombin and thrombin receptor activating peptide in rats

被引:11
|
作者
Sicker, T [1 ]
Wuchold, F [1 ]
Kaiser, B [1 ]
Glusa, E [1 ]
机构
[1] Univ Jena, Fac Med, Ctr Vasc Biol & Med, Unit Expt Angiol, D-99089 Erfurt, Germany
关键词
thrombin; TRAP; vascular effects; blood pressure;
D O I
10.1016/S0049-3848(00)00429-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The proteolytic enzyme thrombin activates its receptor by cleavage of a peptide from the extracellular N-terminus. The newly generated N-terminus acts as a tethered ligand to activate the receptor. Receptor-mediated cellular effects of thrombin can be mimicked by synthetic peptides, which correspond to the amino acid sequence of the newly formed N-terminus. The aim of the present study was to investigate vascular effects of thrombin and the thrombin receptor activating peptide (TRAP: SFLLRN) in vitro and in vivo in rats. In precontracted rat aortic rings, both thrombin (0.3, 1, 3 U/ml) and TRAP (1, 3, 10, 20, 40 muM) induced endothelium-dependent relaxant responses. In anaesthetized rats, the mean arterial blood pressure (MAP) was measured continuously in the carotid artery by a pressure transducer. Thrombin and TRAP were administered as intravenous bolus injection via the femoral vein. Thrombin at doses of 3-100 U/kg, as well as TRAP at doses of 0.1 -0.6 mg/ kg iv, caused a reversible decrease in MAP. Administration of TRAP at doses of 0.3 and 0.6 mg/kg led to a triphasic response in most of the animals treated (50% and 75%, respectively), i.e. a short drop of MAP was followed by an increase and finally a longer lasting decrease in MAP. Pretreatment with the nitric oxide (NO)-synthase inhibitor N-G-nitro-L-arginine-methylester (L-NAME) suppressed the dose-dependent vasodilator effects of thrombin. Heparin and hirudin also inhibited the hypotensive response to thrombin. The TRAP-induced triphasic reaction on MAP was not affected by the serotonin antagonists ketanserin and tropisetron, as well as the aminopeptidase inhibitor amastatin. Pretreatment with L-NAME led to an inhibition of hypotension induced by TRAP at 0.1 mg/kg, as well as of the initial transient fall in blood pressure at doses of 0.3 and 0.6 mg/kg. The studies suggest that the thrombin- and TRAP-induced vasodilation in vitro and in vivo is in part due to the release of endothelial NO. In the blood pressure response to TRAP, additional effects seem to be involved. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:467 / 475
页数:9
相关论文
共 50 条
  • [1] VASCULAR EFFECTS OF THE THROMBIN RECEPTOR ACTIVATING PEPTIDE (TRAP) AND THROMBIN
    GLUSA, E
    PAINTZ, M
    RICHTER, M
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1365 - 1365
  • [2] DISPARATE VASCULAR AND PLATELET EFFECTS OF THROMBIN RECEPTOR ACTIVATING PEPTIDE (TRAP) IN RATS
    CHINTALA, M
    CHIU, PJS
    BERNARDINO, V
    TETZLOFF, G
    TEDESCO, R
    WATKINS, R
    FASEB JOURNAL, 1995, 9 (03): : A562 - A562
  • [3] A peptide analogue of thrombin receptor-activating peptide inhibits thrombin and thrombin-receptor-activating peptide-induced vascular smooth muscle cell proliferation
    Pakala, R
    Liang, CT
    Benedict, CR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 37 (05) : 619 - 629
  • [4] Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in rats
    Chintala, MS
    Chiu, PJS
    Bernadino, V
    Tetzloff, GG
    Tedesco, R
    Sabin, C
    Watkins, RW
    Sybertz, EJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 349 (2-3) : 237 - 243
  • [5] Vasodilating effects of thrombin and thrombin receptor activating peptide (TRAP) after i.v. administration in rats
    Sicker, T
    Wuchold, F
    Kaiser, B
    Glusa, E
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1417 - P1417
  • [6] THROMBIN RECEPTOR-ACTIVATING PEPTIDE SENSITIZES THE HUMAN ENDOTHELIAL THROMBIN RECEPTOR
    KRUSE, HJ
    MAYERHOFER, C
    SIESS, W
    WEBER, PC
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1995, 268 (01): : C36 - C44
  • [7] A peptide ligand of the human thrombin receptor antagonizes thrombin receptor activating peptide and α-thrombin-induced platelet aggregation
    Pakala, R
    Liang, TC
    Benedict, CR
    FIBRINOLYSIS & PROTEOLYSIS, 2000, 14 (01): : 15 - 21
  • [8] EFFECTS OF THROMBIN AND THROMBIN RECEPTOR ACTIVATING PEPTIDES ON RAT AORTIC VASCULAR SMOOTH-MUSCLE
    ANTONACCIO, MJ
    NORMANDIN, D
    SERAFINO, R
    MORELAND, S
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 266 (01): : 125 - 132
  • [9] VASCULAR ACTIONS OF THROMBIN RECEPTOR PEPTIDE
    MURAMATSU, I
    LANIYONU, A
    MOORE, GJ
    HOLLENBERG, MD
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (07) : 996 - 1003
  • [10] DIFFERENT EFFECTS OF THROMBIN AND THROMBIN RECEPTOR ACTIVATING PEPTIDE (TRAP) ON HUMAN GLOMERULAR EPITHELIAL-CELLS
    ZACHARIAS, U
    HE, CJ
    PERALDI, MN
    NGUYEN, G
    SRAER, JD
    RONDEAU, E
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 788 - 788